Cabot Benjamin Graham Value Investor applies the time-tested Buy Low and Sell High investing strategy to bring you market-beating returns with low risk.
J. Royden Ward guides value-oriented investors to market-beating profits with expert stock selection and step-by-step advice. It’s a complete value-oriented advisory, with Maximum Buy and Minimum Sell prices, weekly Updates, Special Bulletins and email access to the analyst.
Benjamin Graham Value Investorrecommends a Cabot Value Model portfolio of 16 low-risk stocks (on which performance calculations are based), and updates approximately 20 previously recommended stocks with specific Maximum Buy and Minimum Sell prices every month. The advisory also presents 16 medium-risk Cabot Enterprising Model stocks and a list of Top 275 Value Stocks, for investors who want to invest in additional value stocks. Subscribers are advised to buy as many of the recommended stocks as appropriate in equal amounts. The Cabot Value Model portfolio performance shown is since the advisory began on December 2, 2002, compared to the S&P 500, not including dividends, as of 5/5/15.
223% in Valeant Pharmaceuticals
57% in Tim Hortons
45% in Actavis
44% in Synaptics
Sign up now for a risk-free trial subscription to Benjamin Graham Value Investor. Try Benjamin Graham Value Investor for 60 days. If you don’t like it, you don’t pay.
Cabot Benjamin Graham Value Investor is a step-by-step guide to low-risk profits with the time-tested value stock investing strategy.
What our Customers say about Benjamin Graham Value Investor
This (Top 275 Value Stocks) chart is awesome thank you so much! Wish I would've joined years ago. I think a lot of self investors would be far more successful if they had a guide as useful as this.
R. Lockheimer, Carlsbad, California
It is the best stock newsletter I've read.
S. Braccey, Los Angeles, California
Roy, Thank you for the information on HQS and JNY. It is the reason I have renewed my subscription to the Cabot Benjamin Graham newsletter for another two years. You are terrific.
T. Lattof, Gloucester, Massachusetts
Are you ready to get started with your risk-free trial subscription?